PinnyPeptide

BPC-157 vs Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

BPC-157

Healing & Recovery

Gastric pentadecapeptide with broad tissue-healing properties.

Peptide B

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Peptide Blends

Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial.

Typical vial

5 mg

Typical dose

250-500 mcg

Half-life

~4 hours (estimated from animal pharmacokinetic data)

FDA status

Not FDA approved for human use. FDA issued a warning letter …

Typical vial

80 mg

Typical dose

500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg

Half-life

KPV ~minutes; BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically

FDA status

No component FDA approved for human use. FDA issued a warnin…

BPC-157 effects

  • Accelerates tendon, ligament, and muscle healing
  • Protects and heals the gastrointestinal lining
  • Promotes angiogenesis and new blood vessel formation
  • Reduces inflammation via nitric oxide modulation
  • Exhibits neuroprotective properties
  • Upregulates growth hormone receptor expression in fibroblasts

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) effects

  • Broad anti-inflammatory action across NF-κB, nitric oxide, and copper-modulation pathways
  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Anti-inflammatory action in the gut and inflamed skin (KPV contribution)
  • Modulates the gut-skin axis (anecdotal, component-derived)
  • Reduces scar formation and supports remodelling
  • Promotes angiogenesis and improved blood flow to repair sites

BPC-157 side effects

  • Nausea at higher doses
  • Dizziness or lightheadedness
  • Injection site redness or irritation
  • Headache

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) side effects

  • Injection site irritation (occasionally with mild bluish tint from copper)
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Possible flushing from MSH-pathway activity (KPV)

BPC-157 dosing ranges

General tissue repair

250-500 mcg · Once or twice daily · 4-6 weeks

Gut healing

250-500 mcg · Twice daily (oral or SubQ) · 4-8 weeks

Acute injury recovery

500 mcg · Twice daily near injury site · 2-4 weeks

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) dosing ranges

Inflammation + recovery loading

500 mcg KPV + 250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · KPV + BPC + GHK daily, TB-500 twice weekly · 6-8 weeks

Gut-skin axis protocol

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · Daily, with TB-500 weekly · 8-12 weeks

Maintenance

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · KPV + BPC 3-4x weekly, others weekly · Ongoing cycles

Full BPC-157 guide → Full Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) guide →

BPC-157 vs Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) — common questions

What is the difference between BPC-157 and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

BPC-157: Gastric pentadecapeptide with broad tissue-healing properties. Typical dose 250-500 mcg. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial. Typical dose 500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg. Both fall under the Healing & Recovery and Peptide Blends categories.

Can you stack BPC-157 and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

Stacking BPC-157 with Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, BPC-157 or Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)?

BPC-157 is typically dosed: Once or twice daily for General tissue repair; Twice daily (oral or SubQ) for Gut healing; Twice daily near injury site for Acute injury recovery. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is typically dosed: KPV + BPC + GHK daily, TB-500 twice weekly for Inflammation + recovery loading; Daily, with TB-500 weekly for Gut-skin axis protocol; KPV + BPC 3-4x weekly, others weekly for Maintenance.

Are BPC-157 and Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) FDA approved?

BPC-157: Not FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.

Related peptide comparisons

ara-290 vs bpc-157b7-33 vs bpc-157bpc-157 vs ghk-cubpc-157 vs glow-blendbpc-157 vs kpvghk-cu vs klow-blend

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free